Offering HIV Prevention Medicine at a Family Planning Clinic
Tests whether patients and doctors accept offering PrEP during family planning visits.
Plain-language title generated from the registry record
Registry title: Bringing Medicines for HIV Prevention to a Family Planning Clinic
Key facts
- Where
- Providence, United StatesSee the site
Where in United States
- Women and Infants Hospital of Rhode IslandProvidence, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Women and Infants Hospital of Rhode Island
- Trial code
- NCT06930508
- Record updated
- 10 November 2026
- Original description
The goal of this clinical trial is to understand what patients and physicians think about providing medications to prevent HIV transmission to patients in a family planning clinic. These medications are known as pre-exposure prophylaxis, or PrEP. The main questions to answer are:Read full original descriptionShow less
Implementing HIV Pre-Exposure Prophylaxis in a Family Planning Clinic: A Study of Feasibility and Acceptability (Aka The Pilot Fish Study)
The goal of this clinical trial is to understand what patients and physicians think about providing medications to prevent HIV transmission to patients in a family planning clinic. These medications are known as pre-exposure prophylaxis, or PrEP. The main questions to answer are:
1. Do patients find it acceptable to be asked about, and offered, PrEP during their visit to a family planning clinic? 2. What things make it easier or harder to ask about PrEP in a family planning clinic setting? 3. What things make it easier or harder to begin PrEP in a family planning clinic setting?
Patient participants:
1. Will receive standardized counseling about PrEP. 2. Will have the opportunity to begin PrEP as part of their routine, ongoing care. 3. Will be asked to complete a survey about their experiences.
Physician participants:
1. Will receive standardized education about PrEP. 2. Will talk to patient participants about PrEP, and support patient participants who want to begin PrEP. 3. Will be asked to complete pre-and post-study surveys about their experiences. 4. May be asked to complete a post-study in-depth interview about their experiences.
This study will include patient participants who:; Are age 16 or older; Are presenting for care at the Women and Infants Hospital of Rhode Island Family Planning Clinic; Speak English or Spanish; Have decisional capacity; This study will exclude patient participants who:; Are currently seeking abortion care; This study will include physician participants who:; Provide care at the Women and Infants Hospital of Rhode Island Family Planning Clinic; This study will not have any specific exclusion criteria for physician participants.